These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1535374)

  • 1. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid.
    Balon HR; Fink-BennetT D; Stoffer SS
    J Nucl Med; 1992 Jul; 33(7):1393-5. PubMed ID: 1535374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
    Bomanji JB; Gacinovic S; Gaze MN; Costa DC; Ell PJ
    Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.
    Scott AM; Kostakoglu L; O'Brien JP; Straus DJ; Abdel-Dayem HM; Larson SM
    J Nucl Med; 1992 Jul; 33(7):1396-8. PubMed ID: 1613584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid.
    Bigsby RJ; Lepp EK; Litwin DE; Wilkinson AA; Matte GG
    Can J Surg; 1992 Aug; 35(4):388-92. PubMed ID: 1323381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
    Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
    Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
    Nakahara H; Noguchi S; Murakami N; Hoshi H; Jinnouchi S; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC; King KL; Yang AH; Liu RS; Yeh SH
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
    Blount CL; Dworkin HJ
    Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans.
    Yen TC; Lin HD; Lee CH; Chang SL; Yeh SH
    Eur J Nucl Med; 1994 Sep; 21(9):980-3. PubMed ID: 7995293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
    Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
    Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy.
    Arnstein NB; Juni JE; Sisson JC; Lloyd RV; Thompson NW
    J Nucl Med; 1986 Oct; 27(10):1564-8. PubMed ID: 3760981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
    Learoyd DL; Roach PJ; Briggs GM; Delbridge LW; Wilmshurst EG; Robinson BG
    J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear imaging in the management of thyroid carcinoma.
    Cavalieri RR
    Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.
    O'Driscoll CM; Baker F; Casey MJ; Duffy GJ
    J Nucl Med; 1991 Dec; 32(12):2281-3. PubMed ID: 1744716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
    Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O
    Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radio-guided surgery for non-131I-avid thyroid cancer.
    Rubello D; Pelizzo MR; Casara D; Piotto A; Toniato A; Fig L; Gross M
    Thyroid; 2006 Nov; 16(11):1105-11. PubMed ID: 17123337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc-99m sestamibi and In-111 pentetreotide uptake in metastatic papillary thyroid carcinoma.
    Lee J; Cutrone JA; Marcus CS
    Clin Nucl Med; 1995 Oct; 20(10):867-8. PubMed ID: 8616988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 20. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
    Tonami N; Hisada K
    Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.